LifeMD, Inc. (LFMD) vs Sutro Biopharma, Inc. (STRO)
A side-by-side comparison of LifeMD, Inc. and Sutro Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LFMD
LifeMD, Inc.
$2.76HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
STRO
Sutro Biopharma, Inc.
$14.62HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — LFMD vs STRO
growth of $100 · dividends reinvested · last 8yLFMD +186.3% (+14.1%/yr)STRO -90.0% (-25.1%/yr)LFMD compounded faster over this window
Log scale — wide-divergence pair
LFMD STRO
LFMD vs STRO: by the numbers
- •STRO is the larger company ($141M vs $133M market cap).
- •Both run net losses; LFMD's is the smaller (-10.40% vs -395.25% net margin).
- •LFMD grew revenue faster over the past five years (26.00% vs 19.13% CAGR).
Metrics side by side
Valuation
| Metric | LFMD | STRO |
|---|---|---|
| P/S ratio | 0.65 | 3.10 |
| P/B ratio | 16.73 | N/A |
Profitability
| Metric | LFMD | STRO |
|---|---|---|
| Gross margin | 85.91% | 97.20% |
| Operating margin | -9.35% | -102.41% |
| Net margin | -10.40% | -395.25% |
| ROE | -266.86% | N/A |
| ROIC | -143.97% | -100.04% |
Growth (annualized)
| Metric | LFMD | STRO |
|---|---|---|
| Revenue CAGR (5Y) | 26.00% | 19.13% |
| Total return CAGR (5Y) | -14.66% | -39.51% |
Frequently asked
- Which has grown faster, LFMD or STRO?
- Over the past five years, LFMD grew revenue faster — LFMD at a 26.00% CAGR versus STRO at 19.13%.
- How have LFMD and STRO total returns compared?
- Over the past 5 years, LFMD delivered -14.66% and STRO delivered -39.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LifeMD ROESutro Biopharma ROELifeMD operating marginSutro Biopharma operating marginLifeMD revenue growthSutro Biopharma revenue growthLifeMD free cash flowSutro Biopharma free cash flow
LifeMD & Sutro Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.